Clinical Trial Update: Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion-3-DES [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating myocardial regeneration and angiogenesis after myocardial infarction using granulocyte colony-stimulating factor with intracor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Neupogen (Filgrastim)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Myocardial Infarction | Phase 2 | Status: COMPLETED